欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号MT/H/0278/001
药品名称Ceftriaxone PharmSol 1000 mg Powder for Solution for Injection/Infusion
活性成分
    • ceftriaxone sodium salt 1000.0 mg
剂型Powder for solution for infusion/injection
上市许可持有人PharmSol Europe Limited The Victoria Centre Unit 2, Lower Ground Floor, Valletta Road, Mosta MST 9012, MALTA
参考成员国 - 产品名称Malta (MT)
Ceftriaxone-PharmSol 1000 mg Powder for Solution for Injection/Infusion
互认成员国 - 产品名称
    • Germany (DE)
      Ceftriaxon PharmSol 1 g Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Latvia (LV)
      Ceftriaxone PharmSol 1000 mg pulveris injekciju/infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Ceftriaxone PharmSol 1000 mg milteliai injekciniam ar infuziniam tirpalui
    • Hungary (HU)
    • Slovenia (SI)
许可日期2020/10/28
最近更新日期2022/08/11
药物ATC编码
    • J01DD04 ceftriaxone
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase